Intraocular Inflammation, Safety Events, and Outcomes After IVT Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD

de ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum